[HTML][HTML] ISTH guidelines for antithrombotic treatment in COVID‐19
S Schulman, M Sholzberg, AC Spyropoulos… - Journal of Thrombosis …, 2022 - Elsevier
Antithrombotic agents reduce risk of thromboembolism in severely ill patients. Patients with
coronavirus disease 2019 (COVID‐19) may realize additional benefits from heparins …
coronavirus disease 2019 (COVID‐19) may realize additional benefits from heparins …
[HTML][HTML] Immuno-thrombotic complications of COVID-19: implications for timing of surgery and anticoagulation
Early in the coronavirus disease 2019 (COVID-19) pandemic, global governing bodies
prioritized transmissibility-based precautions and hospital capacity as the foundation for …
prioritized transmissibility-based precautions and hospital capacity as the foundation for …
[HTML][HTML] Good practice statements for antithrombotic therapy in the management of COVID‐19: guidance from the SSC of the ISTH
Despite the emergence of high quality randomized trial data with the use of antithrombotic
agents to reduce the risk of thromboembolism, end‐organ failure, and possibly mortality in …
agents to reduce the risk of thromboembolism, end‐organ failure, and possibly mortality in …
Outpatient treatment options to address the SARS-CoV-2 variant Omicron
MW McCarthy - Expert Review of Anti-infective Therapy, 2022 - Taylor & Francis
ABSTRACT Introduction On 26 November 2021, the World Health Organization's Technical
Advisory Group on SARS-CoV-2 Virus Evolution designated PANGO lineage B. 1.1. 529 a …
Advisory Group on SARS-CoV-2 Virus Evolution designated PANGO lineage B. 1.1. 529 a …
[HTML][HTML] Venous and arterial thrombosis in ambulatory and discharged COVID-19 patients: a systematic review and meta-analysis
EM Mansory, M Abu-Farhaneh, A Iansavitchene… - TH Open, 2022 - thieme-connect.com
Introduction Venous and arterial thromboses are frequently observed complications in
patients with severe novel coronavirus disease 2019 (COVID-19) infection who require …
patients with severe novel coronavirus disease 2019 (COVID-19) infection who require …
The association between anticoagulation and adverse outcomes after a positive SARS-CoV-2 test among older outpatients: a population-based cohort study
Introduction Anticoagulation may improve outcomes in patients with COVID-19 when started
early in the course of illness. Materials and methods This was a population-based cohort …
early in the course of illness. Materials and methods This was a population-based cohort …
[HTML][HTML] The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
In patients with COVID-19, thromboinflammation is one of the main causes of morbidity and
mortality, which makes anticoagulation an integral part of treatment. However …
mortality, which makes anticoagulation an integral part of treatment. However …
[HTML][HTML] Promising drug fondaparinux for the treatment of COVID-19: an in silico analysis of low molecular weight heparin, direct oral anticoagulant, and antiplatelet …
T Ertan-Bolelli, K Bolelli, SD Elçi… - Cardiovascular Drugs and …, 2022 - Springer
Abstract Purpose As of July 2022, the COVID-19 pandemic has affected over 555 million
worldwide confirmed cases and caused more than 6.3 million deaths. The studies showed …
worldwide confirmed cases and caused more than 6.3 million deaths. The studies showed …
Real-world analysis of thromboembolic events and mortality of COVID-19 outpatients in the United States
WF Peacock, JM Crawford, YW Chen… - Clinical and Applied …, 2022 - journals.sagepub.com
Limited data are available on thromboembolic events (TEEs) and mortality in outpatients
with coronavirus disease 2019 (COVID-19). This retrospective, observational cohort study …
with coronavirus disease 2019 (COVID-19). This retrospective, observational cohort study …
Analysis of deaths and favorable developments of patients with SARS-CoV-2 hospitalized in the largest hospital for infectious diseases and pneumo-phthisiology in …
R Laza, C Dragomir, VF Musta… - … Journal of General …, 2022 - Taylor & Francis
Purpose Romania is one of the European countries that has been hit the hardest by the
severe acute respiratory syndrome caused by the new coronavirus SARS-CoV-2, with over …
severe acute respiratory syndrome caused by the new coronavirus SARS-CoV-2, with over …